Teva licenses glatiramer acetate to Takeda in Japan
Posted: Fri Dec 06, 2013 4:28 am
Teva Pharmaceutical has licensed rights to commercialize glatiramer acetate to Takeda Pharmaceutical in Japan as part of their agreement signed earlier in 2013.<br><br>
Currently both the firms are working on additional agreements for implementation of the license..... Read More - http://www.ms-uk.org/copaxone
Currently both the firms are working on additional agreements for implementation of the license..... Read More - http://www.ms-uk.org/copaxone